Sorin Group snaps up Gish Biomedical
This article was originally published in The Gray Sheet
Executive Summary
Cardiovascular device maker Sorin Group acquires Gish Biomedical, a manufacturer of disposable cardiovascular surgery, orthopedic and oncology devices, for undisclosed terms on June 8. Gish, which is based in Rancho Santa Margarita, Calif., and was formerly owned by private equity firm Ventizz Capital Partners, will strengthen Milan, Italy-based Sorin's offerings for extracorporeal circulation, according to the company. Gish offerings include oxygenators, blood reservoirs, cardioplegia delivery systems, cardiovascular tubing systems, central venous access catheters and ports, and blood recovery devices